Meyka AI API is live for developers.Start building.
Advertisement
Zynerba Pharmaceuticals, Inc.

Why Is Zynerba Pharmaceuticals, Inc. (ZYNE) Stock Down Today?

Live update on ZYNE's stock movement with key data on price change, volume, technical indicators, sector trends, and analyst sentiment.

ZYNENASDAQ
HealthcareDrug Manufacturers - Specialty & Generic
$1.30
$0.03(2.36%)
U.S. Market opens in 46h 59m
Advertisement

ZYNE is Up +2.36% today

You might want to check out Why is ZYNE Up Today?

Zynerba Pharmaceuticals, Inc. (ZYNE)

Volume
861.74K
17.00%
Open / Previous Close
$1.26 / $1.27
Day Range (Low / High)
$1.26 - $1.34

Summary

Zynerba Pharmaceuticals, Inc. (ZYNE) is trading up +2.36% at $1.30, reflecting a positive shift in investor sentiment today. The stock opened at $1.26 and has moved between $1.26 and $1.34 so far.

Trading volume is 861742, which is 17% below its average, and the price action suggests buying interest.

Technically, ZYNE is trading above its 50-day moving average of $1.12 and above its 200-day moving average of $0.61, indicating short-term and long-term strength.

Meyka's AI assigns ZYNE a grade of C (Overall fair), reflecting its assessment of fundamentals and sentiment. Forecast models project potential returns of -100.00% in 1 year ($0.00), and -100.00% in 5 years ($0.00).

View the full chart, check forecasting details, or see the AI grade breakdown to explore what's driving this stock's movement.
Stay informed and make better investment decisions.

ZYNE Technical Signals

Trading over 50-day moving average ($1.12)

Trading over 200-day moving average ($0.61)

Analyst Recommendations data is not available for ZYNEAnalyst Recommendations details for ZYNE are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Price Forecast

1 Month

N/A

1 Year

N/A

3 Years

N/A

5 Years

N/A

C+
Normal59.00

Is this change significant?

5-Day:N/A

1-Month:+2.36%

3-Month:+289.22%

What's next?

Next earnings date: 7/30/2025

Frequently Asked Questions